A review of the growing evidence base for pediatric psychopharmacology

Elizabeth A. Pappadopulos, B. Tate Guelzow, Carrie Wong, Melissa Ortega, Peter S. Jensen

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

This article provides an update of pediatric psychopharmacologic treatment evidence and focuses on six classes of medications in pediatric populations: psychostimulants, mood stabilizers, SSRIs, tricyclic antidepressants, antipsychotic agents, and other agents. The evidence is organized by disorder so that it is most useful to practicing clinicians. We begin each section with a brief introduction and summary of the findings published before January 1998. Priority is given to clinical trials that use random assignment and use of a comparison group (ie, placebo-control, head-to-head comparison, or cross-over design). Serious concerns remain about the efficacy and safety of many of these agents for use in children and adolescents. While a great progress is being made, there is clearly much work left to be done.

Original languageEnglish (US)
Pages (from-to)817-855
Number of pages39
JournalChild and Adolescent Psychiatric Clinics of North America
Volume13
Issue number4
DOIs
StatePublished - Oct 2004
Externally publishedYes

Fingerprint

Psychopharmacology
Pediatrics
Tricyclic Antidepressive Agents
Cross-Over Studies
Antipsychotic Agents
Placebos
Clinical Trials
Safety
Population
Therapeutics

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Pediatrics, Perinatology, and Child Health

Cite this

A review of the growing evidence base for pediatric psychopharmacology. / Pappadopulos, Elizabeth A.; Tate Guelzow, B.; Wong, Carrie; Ortega, Melissa; Jensen, Peter S.

In: Child and Adolescent Psychiatric Clinics of North America, Vol. 13, No. 4, 10.2004, p. 817-855.

Research output: Contribution to journalArticle

Pappadopulos, Elizabeth A. ; Tate Guelzow, B. ; Wong, Carrie ; Ortega, Melissa ; Jensen, Peter S. / A review of the growing evidence base for pediatric psychopharmacology. In: Child and Adolescent Psychiatric Clinics of North America. 2004 ; Vol. 13, No. 4. pp. 817-855.
@article{3b85bd1ec98940099893197b11f89ef3,
title = "A review of the growing evidence base for pediatric psychopharmacology",
abstract = "This article provides an update of pediatric psychopharmacologic treatment evidence and focuses on six classes of medications in pediatric populations: psychostimulants, mood stabilizers, SSRIs, tricyclic antidepressants, antipsychotic agents, and other agents. The evidence is organized by disorder so that it is most useful to practicing clinicians. We begin each section with a brief introduction and summary of the findings published before January 1998. Priority is given to clinical trials that use random assignment and use of a comparison group (ie, placebo-control, head-to-head comparison, or cross-over design). Serious concerns remain about the efficacy and safety of many of these agents for use in children and adolescents. While a great progress is being made, there is clearly much work left to be done.",
author = "Pappadopulos, {Elizabeth A.} and {Tate Guelzow}, B. and Carrie Wong and Melissa Ortega and Jensen, {Peter S.}",
year = "2004",
month = "10",
doi = "10.1016/j.chc.2004.04.007",
language = "English (US)",
volume = "13",
pages = "817--855",
journal = "Child and Adolescent Psychiatric Clinics of North America",
issn = "1056-4993",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - A review of the growing evidence base for pediatric psychopharmacology

AU - Pappadopulos, Elizabeth A.

AU - Tate Guelzow, B.

AU - Wong, Carrie

AU - Ortega, Melissa

AU - Jensen, Peter S.

PY - 2004/10

Y1 - 2004/10

N2 - This article provides an update of pediatric psychopharmacologic treatment evidence and focuses on six classes of medications in pediatric populations: psychostimulants, mood stabilizers, SSRIs, tricyclic antidepressants, antipsychotic agents, and other agents. The evidence is organized by disorder so that it is most useful to practicing clinicians. We begin each section with a brief introduction and summary of the findings published before January 1998. Priority is given to clinical trials that use random assignment and use of a comparison group (ie, placebo-control, head-to-head comparison, or cross-over design). Serious concerns remain about the efficacy and safety of many of these agents for use in children and adolescents. While a great progress is being made, there is clearly much work left to be done.

AB - This article provides an update of pediatric psychopharmacologic treatment evidence and focuses on six classes of medications in pediatric populations: psychostimulants, mood stabilizers, SSRIs, tricyclic antidepressants, antipsychotic agents, and other agents. The evidence is organized by disorder so that it is most useful to practicing clinicians. We begin each section with a brief introduction and summary of the findings published before January 1998. Priority is given to clinical trials that use random assignment and use of a comparison group (ie, placebo-control, head-to-head comparison, or cross-over design). Serious concerns remain about the efficacy and safety of many of these agents for use in children and adolescents. While a great progress is being made, there is clearly much work left to be done.

UR - http://www.scopus.com/inward/record.url?scp=4544336635&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4544336635&partnerID=8YFLogxK

U2 - 10.1016/j.chc.2004.04.007

DO - 10.1016/j.chc.2004.04.007

M3 - Article

VL - 13

SP - 817

EP - 855

JO - Child and Adolescent Psychiatric Clinics of North America

JF - Child and Adolescent Psychiatric Clinics of North America

SN - 1056-4993

IS - 4

ER -